Core Insights - Ronghe Medical has completed nearly 100 million yuan in Series B financing, led by Qiming Venture Partners, to accelerate the clinical promotion and market expansion of its innovative "real-time electromagnetic navigation bronchial rheoplasty" technology for chronic obstructive pulmonary disease (COPD) treatment [2] Group 1: Company Overview - Ronghe Medical Technology (Zhejiang) Co., Ltd. was established in July 2022 and has developed the Breeze One® real-time electromagnetic navigation pulsed electric field ablation system, which received FDA breakthrough device designation in April 2025, marking a significant milestone for China in the respiratory intervention treatment field [2] Group 2: Technology Advantages - The system integrates three-dimensional visual electromagnetic navigation technology, akin to a "bronchial GPS" for doctors, significantly shortening the clinical learning curve and enhancing surgical precision and efficiency [3] - The technology directly ablates abnormal mucus-secreting goblet cells using pulsed electric field technology, reducing phlegm production at the source and alleviating symptoms such as cough and breathing difficulties, thus shifting treatment from symptomatic management to root cause resolution [4] - It employs a non-thermal mechanism to avoid thermal and mechanical damage to surrounding blood vessels, nerves, and cartilage, significantly enhancing surgical safety [5] Group 3: Future Directions - Ronghe Medical aims to continue focusing on cutting-edge life sciences, deepening the expansion and integration of its core technology matrix, and developing original medical device solutions with significant clinical value [6]

该系统具备三大核心创新优势： 采用非热能的物理作用机制，避免对周围血管、神经、软骨等正常组织的热损伤与机械损伤，显著提升 手术安全性。 融和医疗创始人叶萍女士表示："启明创投和荷塘创投，作为公认的备受尊重的顶尖投资机构，对融和 医疗的认可与支持，充分体现了融和医疗源头创新技术实力与其带来的临床重大价值。 融和医疗将持 续致力于探索生命奥秘，拓展、延伸、深化源头创新核心技术，并将这些优势转化为企业品牌影响力和 健康生态的助推力，普及高端科学技术，为临床医生和患者创造宝贵价值。" 启明创投合伙人张奥表示："融和医疗在慢阻肺介入治疗领域实现了真正意义上的原始创新，其技术不 仅具备明确的临床机制和显著的疗效优势，更在全球范围内展现了'中国智造'的科技竞争力。我们看好 该公司在呼吸疾病介入治疗领域的平台价值与全球市场潜力，相信融和医疗将为行业发展与社会福祉创 造卓越价值。" 一、实时电磁导航+靶向消融，双效合一 系统集成三维可视化电磁导航技术，如同为医生安装"支气管GPS"，突破传统支气管镜操作的视觉盲 区，显著缩短临床学习曲线，提升手术精准度与操作效率。同时，实时消融点位记录功能，可有效避免 漏消或重复消融，大幅提升 ...